US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist
  • 5.780
  • -0.120-2.03%
Close Oct 2 16:00 ET
  • 5.940
  • +0.160+2.77%
Post 16:15 ET
171.14MMarket Cap-9131P/E (TTM)

Telomir Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4,435.38%-1.52M
-163.60%-1.94M
-723.58%-3.86M
-325.04%-1.09M
-2,331.29%-2M
-33.58K
-735.74K
-292.53%-468.66K
-255.79K
-82.4K
Net income from continuing operations
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
-632.91%-1.71M
---1.55M
---482.94K
-518.36%-854.15K
---487.1K
---233.5K
Operating gains losses
----
----
--7.49M
----
----
----
----
----
----
----
Other non cash items
--0
--4.34M
--1.61M
--730.23K
--757.17K
----
----
----
----
----
Change In working capital
-105.30%-73.84K
90.76%-23.35K
-70.47%113.84K
-90.06%23K
-794.31%-1.05M
--1.39M
---252.8K
1,957.57%385.49K
--231.31K
--151.1K
-Change in prepaid assets
--11K
---98.1K
---713
--250
---963
--0
--0
--0
--0
----
-Change in payables and accrued expense
-106.09%-84.84K
129.57%74.74K
-70.28%114.56K
-90.16%22.75K
-793.67%-1.05M
--1.39M
---252.8K
1,957.57%385.49K
--231.31K
--151.1K
Cash from discontinued investing activities
Operating cash flow
-4,435.38%-1.52M
-163.60%-1.94M
-723.58%-3.86M
-325.04%-1.09M
-2,331.29%-2M
---33.58K
---735.74K
-292.53%-468.66K
---255.79K
---82.4K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
185.43%132.44K
608.10%5.21M
721.05%3.86M
332.87%1.09M
2,388.86%1.99M
46.4K
736.13K
293.72%470.08K
250.88K
80K
Net issuance payments of debt
-72.86%132.44K
---101K
573.80%3.12M
338.50%1.07M
1,851.60%1.56M
--487.91K
--0
--462.39K
--243.19K
--80K
Net common stock issuance
--0
483.30%5.83M
--1M
--90K
--0
---90K
--1M
--0
--0
--0
Net other financing activities
--0
-96.87%-519.48K
-3,429.04%-255.97K
---70.39K
--429.81K
---351.52K
---263.87K
-93.56%7.69K
----
----
Cash from discontinued financing activities
Financing cash flow
185.43%132.44K
608.10%5.21M
721.05%3.86M
332.87%1.09M
2,388.86%1.99M
--46.4K
--736.13K
293.72%470.08K
--250.88K
--80K
Net cash flow
Beginning cash position
181,101.66%3.27M
-13.25%1.23K
--1.42K
-61.26%2.45K
67.67%14.63K
--1.81K
--1.42K
--0
--6.33K
--8.73K
Current changes in cash
-10,943.90%-1.39M
843,478.09%3.27M
-113.25%-188
75.14%-1.22K
-408.43%-12.18K
--12.82K
--388
--1.42K
---4.91K
---2.4K
End cash Position
12,777.91%1.88M
181,101.66%3.27M
-13.25%1.23K
-13.25%1.23K
-61.26%2.45K
--14.63K
--1.81K
--1.42K
--1.42K
--6.33K
Free cash flow
-4,435.38%-1.52M
-163.60%-1.94M
-723.58%-3.86M
-325.04%-1.09M
-2,331.29%-2M
---33.58K
---735.74K
-292.53%-468.66K
---255.79K
---82.4K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4,435.38%-1.52M-163.60%-1.94M-723.58%-3.86M-325.04%-1.09M-2,331.29%-2M-33.58K-735.74K-292.53%-468.66K-255.79K-82.4K
Net income from continuing operations 6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M-632.91%-1.71M---1.55M---482.94K-518.36%-854.15K---487.1K---233.5K
Operating gains losses ----------7.49M----------------------------
Other non cash items --0--4.34M--1.61M--730.23K--757.17K--------------------
Change In working capital -105.30%-73.84K90.76%-23.35K-70.47%113.84K-90.06%23K-794.31%-1.05M--1.39M---252.8K1,957.57%385.49K--231.31K--151.1K
-Change in prepaid assets --11K---98.1K---713--250---963--0--0--0--0----
-Change in payables and accrued expense -106.09%-84.84K129.57%74.74K-70.28%114.56K-90.16%22.75K-793.67%-1.05M--1.39M---252.8K1,957.57%385.49K--231.31K--151.1K
Cash from discontinued investing activities
Operating cash flow -4,435.38%-1.52M-163.60%-1.94M-723.58%-3.86M-325.04%-1.09M-2,331.29%-2M---33.58K---735.74K-292.53%-468.66K---255.79K---82.4K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 185.43%132.44K608.10%5.21M721.05%3.86M332.87%1.09M2,388.86%1.99M46.4K736.13K293.72%470.08K250.88K80K
Net issuance payments of debt -72.86%132.44K---101K573.80%3.12M338.50%1.07M1,851.60%1.56M--487.91K--0--462.39K--243.19K--80K
Net common stock issuance --0483.30%5.83M--1M--90K--0---90K--1M--0--0--0
Net other financing activities --0-96.87%-519.48K-3,429.04%-255.97K---70.39K--429.81K---351.52K---263.87K-93.56%7.69K--------
Cash from discontinued financing activities
Financing cash flow 185.43%132.44K608.10%5.21M721.05%3.86M332.87%1.09M2,388.86%1.99M--46.4K--736.13K293.72%470.08K--250.88K--80K
Net cash flow
Beginning cash position 181,101.66%3.27M-13.25%1.23K--1.42K-61.26%2.45K67.67%14.63K--1.81K--1.42K--0--6.33K--8.73K
Current changes in cash -10,943.90%-1.39M843,478.09%3.27M-113.25%-18875.14%-1.22K-408.43%-12.18K--12.82K--388--1.42K---4.91K---2.4K
End cash Position 12,777.91%1.88M181,101.66%3.27M-13.25%1.23K-13.25%1.23K-61.26%2.45K--14.63K--1.81K--1.42K--1.42K--6.33K
Free cash flow -4,435.38%-1.52M-163.60%-1.94M-723.58%-3.86M-325.04%-1.09M-2,331.29%-2M---33.58K---735.74K-292.53%-468.66K---255.79K---82.4K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data